Recent studies reveal increased Nrf2 levels in several cancers whereby the cytoprotective role of Nrf2 promotes cancer cell proliferation thus implying that inhibition of Nrf2 during cancer therapy may be of significance [109]. This evidence concerns the gene NFE2L2 and cancer.